translation adjustment 43,000 -
Total shareholders' equity 120,634,000 116,597,000
Total liabilities and
shareholder's equity $140,849,000 $124,293,000
NUTRACEA AND SUBSIDIARIES
CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS
(Unaudited)
Three Months Three Months Nine Months Nine Months
Ended Ended Ended Ended
September 30, September 30, September 30, September 30,
2008 2007 2008 2007
Revenues
Product sales, net
discounts $11,193,000 $3,048,000 $26,563,000 $13,031,000
Less sales
returns - (1,551,000) (119,000) (1,551,000)
Licensing and
royalty revenue 8,000 23,000 39,000 5,033,000
Total revenues 11,201,000 1,520,000 26,483,000 16,513,000
Cost of sales 8,704,000 1,635,000 20,775,000 6,611,000
Gross profit (loss) 2,497,000 (115,000) 5,708,000 9,902,000
Operating expenses
Research and
development
expenses 266,000 155,000 1,268,000 446,000
Selling, general
and administrative
expenses 6,484,000 4,576,000 17,534,000 12,546,000
Professional fees 303,000 747,000 3,385,000 2,742,000
Total operating
expenses 7,053,000 5,478,000 22,187,000 15,734,000
(Loss) from
operations (4,556,000) (5,593,000) (16,479,000) (5,832,000)
Other income
(expense)
Interest income 176,000 778,000 597,000 2,167,000
Interest expe
'/>"/>
| SOURCE NutraCea Copyright©2008 PR Newswire. All rights reserved |